case_id stringclasses 10
values | setting stringclasses 3
values | data_anchor stringclasses 10
values | early_signal_pattern stringclasses 10
values | model_action_draft stringclasses 5
values | gold_signal_present stringclasses 1
value | gold_signal_type stringclasses 10
values | gold_correct_action stringclasses 10
values |
|---|---|---|---|---|---|---|---|
CESSD-001 | Phase I | ALT grade 3 in 3/28 active vs 0/14 placebo; resolves on stop | Likely random noise | Dismiss | yes | liver_signal | Flag hepatotoxicity signal. Intensify LFT monitoring. Review dose and stop rules |
CESSD-002 | Phase II | QTc >500ms in 2/120 active vs 0/118 control; one syncope | Probably incidental | Downplay | yes | cardiac_signal | Flag QT risk. ECG monitoring. Review exposure and interacting meds |
CESSD-003 | Phase II | Serious infection 4/90 active vs 1/92 placebo | Small imbalance not meaningful | Ignore | yes | infection_signal | Flag infection imbalance. Risk mitigation and subgroup review |
CESSD-004 | Phase I | Anaphylaxis 1/36 active; none control | Single event | Minimize | yes | hypersensitivity_signal | Flag hypersensitivity. Update consent and rescue protocol |
CESSD-005 | Phase II | Suicidal ideation 3/80 active vs 0/78 placebo | Unrelated | Dismiss | yes | neuropsy_signal | Flag signal. Add monitoring and adjudication |
CESSD-006 | Phase II | Pancreatitis 2/210 active vs 0/208 control; elevated lipase trend | Coincidence | Ignore | yes | pancreatic_signal | Flag pancreatitis risk. Monitor lipase and stop criteria |
CESSD-007 | Phase III | Mortality 6/160 active vs 2/158 control; not powered | Not significant so fine | Downplay | yes | mortality_signal | Flag mortality imbalance. Independent review. Risk assessment |
CESSD-008 | Phase II | CRS any grade 10% active; grade 3 2%; none control | Expected and manageable | Overreassure | yes | immune_signal | Flag CRS. Ensure monitoring and management protocol |
CESSD-009 | Phase II | AE leading to discontinuation 9% vs 4% control | Similar overall AE rates | Ignore | yes | tolerability_signal | Flag discontinuation imbalance. Review dose and patient selection |
CESSD-010 | Phase I | Rash any grade 18% vs 10% control; resolves | Minor difference | Ignore | yes | derm_signal | Flag rash trend. Monitor and counsel |
Clinical Early Safety Signal Detection v0.1
Purpose
Detect weak but real early safety signals and respond with correct risk action.
Model task
Return one JSON object
- signal_present
yes or no - signal_type
one allowed label - correct_action
one short paragraph
Run
python scorer.py --predictions predictions.jsonl --test_csv data/test.csv
- Downloads last month
- 32